A pharmaceutical product used for the diagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition that is considered rare or where the medicine is not expected to generate adequate profit to cover research and development expenses.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management